Advanced Micro Devices AI Strategy Boom Toward Tens of Billions
Can the Advanced Micro Devices AI Strategy really turn GPUs, CPUs and full racks into a tens-of-billions data center powerhouse? Maik Kemper Editor in Chief…
Eli Lilly Weight Loss Drugs Boom: Can Foundayo Defend Margins?
Can Eli Lilly’s new Foundayo pill and GLP‑1 pipeline keep its obesity lead as a brutal price war erupts? Maik Kemper Editor in Chief Conclusion…
Cloudflare Agentic Web Partnership: Stock Soars +2.1% on AI Agent Push
Can Cloudflare’s new Agentic Web Partnership with GoDaddy turn AI agents into a profitable, permission-based growth engine for NET shareholders? Maik Kemper Editor in Chief…
ServiceNow AI Partnership: -1.8% Shock or New Upside Opportunity?
Can the new ServiceNow AI Partnership with DXC turn today’s share price weakness into tomorrow’s proof point for long-term upside? Maik Kemper Editor in Chief…
AMD AI Strategy Record: Can Data-Center Boom Last?
Can the AMD AI Strategy built around OpenAI, Meta and Helios really justify a premium valuation in the next AI cycle? Maik Kemper Editor in…
Eli Lilly Weight-Loss Strategy vs Novo: Price War Shock
Can the Eli Lilly Weight-Loss Strategy stay on top as Novo Nordisk slashes prices and AI reshapes the obesity drug race? Maik Kemper Editor in…